Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand

J. A. Trubiano, A. C. Cheng, T. M. Korman, C. Roder, A. Campbell, M. L A May, C. C. Blyth, J. K. Ferguson, T. K. Blackmore, T. V. Riley, E. Athan

Research output: Contribution to journalArticleResearchpeer-review

Abstract

The incidence of Clostridium difficile infection (CDI) continues to rise, whilst treatment remains problematic due to recurrent, refractory and potentially severe nature of disease. The treatment of C. difficile is a challenge for community and hospital-based clinicians. With the advent of an expanding therapeutic arsenal against C. difficile since the last published Australasian guidelines, an update on CDI treatment recommendations for Australasian clinicians was required. On behalf of the Australasian Society of Infectious Diseases, we present the updated guidelines for the management of CDI in adults and children.

Original languageEnglish
Pages (from-to)479-493
Number of pages15
JournalInternal Medicine Journal
Volume46
Issue number4
DOIs
Publication statusPublished - 1 Apr 2016

Keywords

  • Clostridium difficile
  • Faecal microbiota transplant (FMT)
  • Fidaxomicin
  • Metronidazole
  • Treatment
  • Vancomycin

Cite this

Trubiano, J. A. ; Cheng, A. C. ; Korman, T. M. ; Roder, C. ; Campbell, A. ; May, M. L A ; Blyth, C. C. ; Ferguson, J. K. ; Blackmore, T. K. ; Riley, T. V. ; Athan, E. / Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand. In: Internal Medicine Journal. 2016 ; Vol. 46, No. 4. pp. 479-493.
@article{856324b3ee4043cba55bdcf694f84b2f,
title = "Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand",
abstract = "The incidence of Clostridium difficile infection (CDI) continues to rise, whilst treatment remains problematic due to recurrent, refractory and potentially severe nature of disease. The treatment of C. difficile is a challenge for community and hospital-based clinicians. With the advent of an expanding therapeutic arsenal against C. difficile since the last published Australasian guidelines, an update on CDI treatment recommendations for Australasian clinicians was required. On behalf of the Australasian Society of Infectious Diseases, we present the updated guidelines for the management of CDI in adults and children.",
keywords = "Clostridium difficile, Faecal microbiota transplant (FMT), Fidaxomicin, Metronidazole, Treatment, Vancomycin",
author = "Trubiano, {J. A.} and Cheng, {A. C.} and Korman, {T. M.} and C. Roder and A. Campbell and May, {M. L A} and Blyth, {C. C.} and Ferguson, {J. K.} and Blackmore, {T. K.} and Riley, {T. V.} and E. Athan",
year = "2016",
month = "4",
day = "1",
doi = "10.1111/imj.13027",
language = "English",
volume = "46",
pages = "479--493",
journal = "Internal Medicine Journal",
issn = "1444-0903",
publisher = "Wiley-Blackwell",
number = "4",

}

Trubiano, JA, Cheng, AC, Korman, TM, Roder, C, Campbell, A, May, MLA, Blyth, CC, Ferguson, JK, Blackmore, TK, Riley, TV & Athan, E 2016, 'Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand' Internal Medicine Journal, vol. 46, no. 4, pp. 479-493. https://doi.org/10.1111/imj.13027

Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand. / Trubiano, J. A.; Cheng, A. C.; Korman, T. M.; Roder, C.; Campbell, A.; May, M. L A; Blyth, C. C.; Ferguson, J. K.; Blackmore, T. K.; Riley, T. V.; Athan, E.

In: Internal Medicine Journal, Vol. 46, No. 4, 01.04.2016, p. 479-493.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand

AU - Trubiano, J. A.

AU - Cheng, A. C.

AU - Korman, T. M.

AU - Roder, C.

AU - Campbell, A.

AU - May, M. L A

AU - Blyth, C. C.

AU - Ferguson, J. K.

AU - Blackmore, T. K.

AU - Riley, T. V.

AU - Athan, E.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - The incidence of Clostridium difficile infection (CDI) continues to rise, whilst treatment remains problematic due to recurrent, refractory and potentially severe nature of disease. The treatment of C. difficile is a challenge for community and hospital-based clinicians. With the advent of an expanding therapeutic arsenal against C. difficile since the last published Australasian guidelines, an update on CDI treatment recommendations for Australasian clinicians was required. On behalf of the Australasian Society of Infectious Diseases, we present the updated guidelines for the management of CDI in adults and children.

AB - The incidence of Clostridium difficile infection (CDI) continues to rise, whilst treatment remains problematic due to recurrent, refractory and potentially severe nature of disease. The treatment of C. difficile is a challenge for community and hospital-based clinicians. With the advent of an expanding therapeutic arsenal against C. difficile since the last published Australasian guidelines, an update on CDI treatment recommendations for Australasian clinicians was required. On behalf of the Australasian Society of Infectious Diseases, we present the updated guidelines for the management of CDI in adults and children.

KW - Clostridium difficile

KW - Faecal microbiota transplant (FMT)

KW - Fidaxomicin

KW - Metronidazole

KW - Treatment

KW - Vancomycin

UR - http://www.scopus.com/inward/record.url?scp=84962852766&partnerID=8YFLogxK

U2 - 10.1111/imj.13027

DO - 10.1111/imj.13027

M3 - Article

VL - 46

SP - 479

EP - 493

JO - Internal Medicine Journal

JF - Internal Medicine Journal

SN - 1444-0903

IS - 4

ER -